FMR LLC 13D and 13G filings for Evelo Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-06-12 08:21 am Sale | 2023-06-09 | 13G | Evelo Biosciences, Inc. EVLO | FMR LLC | 489,782 8.746% | -331,635 (-40.37%) | Filing |
| 2023-02-09 10:59 am Purchase | 2023-02-09 | 13G | Evelo Biosciences, Inc. EVLO | FMR LLC | 821,418 14.987% | 420,468 (+104.87%) | Filing |
| 2022-02-09 09:11 am Purchase | 2022-02-08 | 13G | Evelo Biosciences, Inc. EVLO | FMR LLC | 400,950 14.999% | 60,781 (+17.87%) | Filing |
| 2021-02-08 10:21 am Purchase | 2021-02-05 | 13G | Evelo Biosciences, Inc. EVLO | FMR LLC | 340,168 14.729% | 178,047 (+109.82%) | Filing |
| 2020-02-07 11:18 am Sale | 2020-02-06 | 13G | Evelo Biosciences, Inc. EVLO | FMR LLC | 162,121 10.105% | -3,179 (-1.92%) | Filing |